News and Insights from Our Multidisciplinary Team of Experts
Dr. Roberto Gianani and Michael Koratich Named to Key Medical and Pharma RolesWestminster, CO – March 10, 2021 – Flagship Biosciences, the leader in data-centric pathology and tissue analysis, today announced strategic additions to its executive team. Dr. Roberto...
Patent Number 10,839,512 Issued for New Tissue Sample Image Dot Detection MethodWestminster, CO – February 17, 2021 – Flagship Biosciences, the leader in data-centric pathology tissue analysis, today announced that the United States Patent and Trademark Office has...
The new technical partnership between Inspirata and Flagship Biosciences provides clinicians with a seamless, fully automated AI send-out solution, offering significant advantages over standard material transfers.Tampa, FL and Westminster, CO – (Globe Newswire)...
As one of the industry’s leading tissue data and image analysis services providers, Flagship Biosciences was recently selected as a Top Image Analysis Solution Provider for 2020. With advanced tissue image analysis solutions that give pharmaceutical and diagnostics...
As featured in Pharma Tech Outlook Magazine, July 2020Flagship Biosciences was recently selected as a Top Image Analysis Solution Provider for 2020 by Pharma Tech Outlook Magazine. Flagship’s proprietary tissue image analysis solutions provide both pharmaceutical and...
Brenna O’Neill, Image Analyst for Flagship Biosciences, received her M.S. Ecology and B.S. Marine Biology at Florida Institute of Technology. Brenna knew from a very young age that she would be some kind of scientist. She recently shared more about the early life...
Sign up to receive industry and company news, including The Cut Point, Flagship’s quarterly e-newsletter.
PUBLICATIONS/POSTERS
Summary View a scientific, collaborative success with our client, Heat Biologics, presented at the European Society for Medical Oncology (ESMO) Virtual Congress 2020 medical oncology conference. We cover image analysis of tumor infiltrating lymphocytes (TIL) and more.
ABSTRACT PD-L1 positivity in tumor-associated macrophages has been related to a favorable response to anti-PD-1 and PD-L1 targeted therapies. This concept has driven interest in specifically identifying macrophages in PD-L1 stained tissues, but pathologists often have...
BACKGROUND F-06647020, an ADC comprising a humanized monoclonal antibody against PTK7, a cleavable valine-citrulline linker, and an auristatin payload, is being investigated in an ongoing Phase I clinical trial in patients with advanced solid tumors. We hypothesized...
EVENTS
Visit us at booth 821 at the ASGCT Annual Meeting. We help you analyze more data in more depth, so you can produce more effective therapies. Attending the ASGCT Annual Meeting? Schedule a meeting with our team to discuss our: AI-powered digital pathology solutions...
Visit Us at Booth 2866 in the West Building, Level 2 Flagship Biosciences is your source for spatial biology expertise, moving your research forward every step of the way. Our mission is to explore complex biomarkers within the context of disease in order to advance...
Reuniting 100+ leading experts in biotech, pharma, and academia. February 21-23, 2023. We’re headed to Boston to join other leading experts in biotech, pharma and academia to discuss obstacles in clinical trials and strategies for delivering safer and more effective...